MIBio 2024

We are delighted to announce that the 12th MIBio conference will take place at the Howard Theatre, Downing College, Cambridge, on 4 December 2024.

MIBio engages leading experts from industry and academia in a discussion on how the latest molecular interaction based discoveries can be exploited in biopharmaceutical formulation to deliver more effective, patient-friendly, and safer therapeutic products.

The 2024 meeting will primarily focus on subcutaneous delivery. In spite of advances in other dosage forms and routes of administration over the last decade, subcutaneous products dominate the biopharmaceutical pipelines of Pharma and Biotech companies due to their simplicity, reliability and suitability for self-administration. The trend is further fuelled by continuous improvements of delivery devices and their digital connectivity. The state-of-the-art of the subcutaneous delivery will be discussed at MIBio 2024 as well as possible future trends. However, we will also focus on other challenges including bioavailability, and ways of addressing them.

We expect around 100 delegates from biopharma industry, academia and technology suppliers to create a stimulating event fostering new collaborations and discoveries that will help steer the development of the next generation of drug products. We will be inviting abstracts for poster submissions and welcome applications for sponsor and exhibitor slots on the day.

We look forward to seeing you at MIBio 2024!

MIBio Organising Committee

Jan Jezek | Arecor

Nicholas J Darton | AstraZeneca

Tejash Shah | GSK

Stephen Harding | University of Nottingham

Bernardo Perez-Ramirez | Sanofi

Bin Yang | AstraZeneca

Thank you to the support of The Royal Society of Chemistry